NUTRA PHARMA CORP. Interest on Convertible Debt, Net of Tax
NUTRA PHARMA CORP. (NPHC) reported Interest on Convertible Debt, Net of Tax of $53.08 thousand for the 3-month period ending 2025-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Notes
us-gaap:InterestOnConvertibleDebtNetOfTax · last filed 2026-08-19
- NUTRA PHARMA CORP. interest on convertible debt, net of tax for the quarter ending 2025-06-30 was $53.08K.
- NUTRA PHARMA CORP. interest on convertible debt, net of tax for the quarter ending 2022-12-31 was $54.93K.
- NUTRA PHARMA CORP. interest on convertible debt, net of tax for the quarter ending 2022-09-30 was $61.31K, a 32.96% decline year-over-year.
- NUTRA PHARMA CORP. interest on convertible debt, net of tax for the quarter ending 2022-06-30 was $69.67K, a 19.44% increase year-over-year.
- NUTRA PHARMA CORP. interest on convertible debt, net of tax for fiscal 2022 was $268.92K.
| Period end | Interest on Convertible Debt, Net of Tax 3 month | Interest on Convertible Debt, Net of Tax 6 month | Interest on Convertible Debt, Net of Tax 9 month | Interest on Convertible Debt, Net of Tax 12 month |
|---|---|---|---|---|
| 2025-06-30 | $53.08K 10-Q · filed 2026-08-19 | |||
| 2022-12-31 | $54.93K derived: 10-K 12 month − 10-Q 9 month · filed 2025-11-24 | $116.24K derived: sum of 2 quarters · filed 2025-11-24 | $185.91K derived: sum of 3 quarters · filed 2025-11-24 | $268.92K 10-K · filed 2025-11-24 |
| 2022-09-30 | $61.31K 10-Q · filed 2025-10-28 | $130.99K derived: sum of 2 quarters · filed 2025-10-28 | $214.00K 10-Q · filed 2025-10-28 | |
| 2022-06-30 | $69.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-10-23 | $152.68K 10-Q · filed 2025-10-23 | ||
| 2022-03-31 | $83.01K 10-Q · filed 2025-10-16 | |||
| 2021-09-30 | $91.45K 10-Q · filed 2022-11-21 | $149.78K derived: sum of 2 quarters · filed 2022-11-21 | ||
| 2021-06-30 | $58.33K 10-Q · filed 2022-08-22 | |||
| 2020-09-30 | $7.17K 10-Q · filed 2021-11-10 | $14.60K derived: sum of 2 quarters · filed 2021-11-10 | $23.34K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $7.43K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-09-24 | $16.17K 10-Q · filed 2021-09-24 | ||
| 2020-03-31 | $8.73K 10-Q · filed 2021-09-17 |